Ftse Mib
34.672,29
0,52%
DAX
18.606,36
0,67%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
68.833,44
1,60%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Dr Reddys Laboratories Ltd (RDY) Dr Reddys Laboratories Ltd (RDY) Notizie

Dr Reddys Laboratories Ltd

RDY
68,68
0,00 (0,00%)
03 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
31/5/202413:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/5/202417:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/5/202417:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/5/202412:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202415:53BWDr. Reddy's Laboratories Announces the Appointment of Milan..
28/5/202413:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202419:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202419:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/5/202419:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/5/202416:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/5/202416:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/5/202416:05BWAlvotech and Dr. Reddy’s Enter Into Collaboration for..
21/5/202414:00GLOBEAlvotech and Dr. Reddy’s enter into collaboration for..
17/5/202415:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/5/202420:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/5/202421:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/5/202412:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/5/202418:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/5/202412:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/5/202420:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/5/202416:31BWDr. Reddy’s Q4 & Full Year FY24 Financial Results
07/5/202412:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/5/202414:00BWDr. Reddy's Laboratories Announces the Launch of Doxycycline..
22/3/202412:00GLOBEPharmazz Inc. and Dr. Reddy's Laboratories have entered into..
19/3/202412:00BWDr. Reddy's Laboratories launches Versavo® (bevacizumab) in..
04/3/202412:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202412:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202412:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202412:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202412:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/2/202412:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/2/202414:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202412:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202412:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/2/202418:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/2/202416:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/2/202412:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202415:44BWDr. Reddy’s Q3 & 9M FY24 Financial Results
31/1/202413:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202420:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202419:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202417:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202412:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/1/202416:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202419:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202417:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202414:58DJNIndian Dr. Reddy's in Talks to Buy Haleon's Nicotinell, Sky..
16/1/202412:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202414:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202412:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: Min: Max:
Chiusura: 68,68

La tua Cronologia

NYSE
RDY
Dr Reddys Laboratories
BIT
P1TDY5
NLBNPIT1TDY5 20240621 55
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network